Pfizer to unveil R&D job cuts

Pfizer is preparing to announce layoffs in its R&D operations. The drug giant has three big R&D operations in the US, including one in La Jolla, California. The company was staying tight-lipped about its plans, though, saying it would reveal the numbers later.

- read this story from the San Diego Union-Tribune for more

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.